n-Lorem Foundation



n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotides (ASO) medicines to treat patients with ultra-rare diseases (<10 patients).

C. Frank Bennett
Chief Technical Officer
Walter Singleton
Chief Medical Officer
Claire Grezemkovsky
Director of Philanthropy
Matt Buck
Head of Regulatory Affairs
Kim Butler
Operations Specialist & Senior Administrator

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.